Cargando…

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer

BACKGROUND: We evaluated the association between a KRAS mutational status and various clinicopathologic features including the metastatic pattern in patients with metastatic or recurrent colorectal cancer (MRCRC). The concordance rates of the KRAS status between primary tumor sites and paired metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Mi-Jung, Lee, Hye Seung, Kim, Jee Hyun, Kim, Yu Jung, Kwon, Ji Hyun, Lee, Jeong-Ok, Bang, Soo-Mee, Park, Kyoung Un, Kim, Duck-Woo, Kang, Sung-Bum, Kim, Jae-Sung, Lee, Jong Seok, Lee, Keun-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488475/ https://www.ncbi.nlm.nih.gov/pubmed/22876814 http://dx.doi.org/10.1186/1471-2407-12-347

Ejemplares similares

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis
por: Nam, Soo Kyung, et al.
Publicado: (2016)

MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
por: Kim, Hyojin, et al.
Publicado: (2016)

KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2016)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017)

Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value
por: Ahn, Hong-Min, et al.
Publicado: (2023)

Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
por: Oh, Ji Eun, et al.
Publicado: (2020)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014)

p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer
por: Sim, Sung Hoon, et al.
Publicado: (2014)

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
por: Kim, Seung Tae, et al.
Publicado: (2015)

Classification of hepatobiliary scintigraphy patterns in segmented gallbladder according to anatomical discordance
por: Lee, Yun-Chae, et al.
Publicado: (2023)

Disparity in Health Screening and Health Utilization according to Economic Status
por: Kim, Min Jung, et al.
Publicado: (2017)

Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group
por: Shin, Jinho, et al.
Publicado: (2015)

Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations
por: Lee, Hyun Jung, et al.
Publicado: (2020)

Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
por: Huang, Chi-Jung, et al.
Publicado: (2016)

Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients
por: Kim, Yoonjung, et al.
Publicado: (2013)

KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location
por: Tabuso, M., et al.
Publicado: (2020)

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
por: Kim, Seung Tae, et al.
Publicado: (2014)

Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status
por: Lee, Jung Won, et al.
Publicado: (2017)

Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
por: Kim, Se Hyun, et al.
Publicado: (2017)

Matrine suppresses KRAS‐driven pancreatic cancer growth by inhibiting autophagy‐mediated energy metabolism
por: Cho, Young‐ra, et al.
Publicado: (2018)

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
por: Moon, Sung-Ung, et al.
Publicado: (2015)

Improvement of digital PCR conditions for direct detection of KRAS mutations
por: Lee, Jina, et al.
Publicado: (2020)

An atypical case of Noonan syndrome with KRAS mutation diagnosed by targeted exome sequencing
por: Kim, Jinsup, et al.
Publicado: (2017)

Screening of important metabolites and KRAS genotypes in colon cancer using secondary ion mass spectrometry
por: Cho, Kookrae, et al.
Publicado: (2020)

Activation of KRAS promotes the mesenchymal features of basal-type breast cancer
por: Kim, Rae-Kwon, et al.
Publicado: (2015)

Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
por: Lee, Eunyoung, et al.
Publicado: (2016)

Serum vitamin D status in children and adolescence with diabetes according to season and age
por: Jung, Sung Su, et al.
Publicado: (2014)

Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey
por: Lee, Jeong-Ok, et al.
Publicado: (2014)

Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
por: Yoo, Shin Hye, et al.
Publicado: (2017)

Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation
por: Lee, Hyoun Wook, et al.
Publicado: (2022)

The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
por: Kim, Hye Ryun, et al.
Publicado: (2013)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
por: Song, Changhoon, et al.
Publicado: (2018)

The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to Disease Status, and Its Prognostic Significance
por: Park, Sung-Woo, et al.
Publicado: (2019)

The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
por: Chang, Kuang-Leei, et al.
Publicado: (2016)

Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)

Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
por: Cho, Jung Rae, et al.
Publicado: (2022)

Subclinical alterations in left ventricular structure and function according to obesity and metabolic health status
por: Lee, Hyun-Jung, et al.
Publicado: (2019)

Clinical features and KRAS mutation in colorectal cancer with bone metastasis
por: Park, Hyung Soon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_05ubf05bh1eekd3vggjn1igrq5